Literature DB >> 9837750

TLE, the human homolog of groucho, interacts with AML1 and acts as a repressor of AML1-induced transactivation.

Y Imai1, M Kurokawa, K Tanaka, A D Friedman, S Ogawa, K Mitani, Y Yazaki, H Hirai.   

Abstract

The AML1 gene encodes DNA-binding proteins that contain the Runt domain and is found at the breakpoints of some translocations associated with leukemias. It has been reported that AML1 plays pivotal roles in myeloid differentiation, probably through the transcriptional regulation of various hematopoietic genes. Here we demonstrate the physical and the functional interaction between AML1 and TLE1 (transducin-like Enhancer of split) human homolog of Groucho that is known to be a corepressor of Hairy-related proteins. TLE1 binds to AML1 through the Runt domain and the C terminus of AML1 that includes the VWRPY motif. The interaction is mainly mediated by the SP domain of TLE1. Moreover, TLE1 inhibits AML1-induced transactivation of the target promoters through the C terminus of AML1. These results suggest that TLE1 acts as a repressor of AML1 and provide important insights into the mechanism of the negative regulation of the AML1 functions in hematopoiesis and leukemogenesis. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9837750     DOI: 10.1006/bbrc.1998.9705

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  30 in total

1.  Activation of AML1-mediated transcription by MOZ and inhibition by the MOZ-CBP fusion protein.

Authors:  I Kitabayashi; Y Aikawa; L A Nguyen; A Yokoyama; M Ohki
Journal:  EMBO J       Date:  2001-12-17       Impact factor: 11.598

Review 2.  The notch pathway: modulation of cell fate decisions in hematopoiesis.

Authors:  K Ohishi; B Varnum-Finney; I D Bernstein
Journal:  Int J Hematol       Date:  2002-06       Impact factor: 2.490

3.  Biological characteristics of the leukemia-associated transcriptional factor AML1 disclosed by hematopoietic rescue of AML1-deficient embryonic stem cells by using a knock-in strategy.

Authors:  T Okuda; K Takeda; Y Fujita; M Nishimura; S Yagyu; M Yoshida; S Akira; J R Downing; T Abe
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

Review 4.  Role of RUNX1 in hematological malignancies.

Authors:  Raman Sood; Yasuhiko Kamikubo; Paul Liu
Journal:  Blood       Date:  2017-02-08       Impact factor: 22.113

5.  Roles of HIPK1 and HIPK2 in AML1- and p300-dependent transcription, hematopoiesis and blood vessel formation.

Authors:  Yukiko Aikawa; Lan Anh Nguyen; Kyoichi Isono; Nobuyuki Takakura; Yusuke Tagata; M Lienhard Schmitz; Haruhiko Koseki; Issay Kitabayashi
Journal:  EMBO J       Date:  2006-08-17       Impact factor: 11.598

6.  Filamin A-bound PEBP2beta/CBFbeta is retained in the cytoplasm and prevented from functioning as a partner of the Runx1 transcription factor.

Authors:  Naomi Yoshida; Takehiro Ogata; Kenji Tanabe; Songhua Li; Megumi Nakazato; Kazuyoshi Kohu; Toshiro Takafuta; Sandor Shapiro; Yasutaka Ohta; Masanobu Satake; Toshio Watanabe
Journal:  Mol Cell Biol       Date:  2005-02       Impact factor: 4.272

Review 7.  Cell cycle and developmental control of hematopoiesis by Runx1.

Authors:  Alan D Friedman
Journal:  J Cell Physiol       Date:  2009-06       Impact factor: 6.384

8.  Groucho/transducin-like Enhancer-of-split (TLE)-dependent and -independent transcriptional regulation by Runx3.

Authors:  Merav Yarmus; Eilon Woolf; Yael Bernstein; Ofer Fainaru; Varda Negreanu; Ditsa Levanon; Yoram Groner
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-01       Impact factor: 11.205

9.  PEBP2-beta/CBF-beta-dependent phosphorylation of RUNX1 and p300 by HIPK2: implications for leukemogenesis.

Authors:  Hee-Jun Wee; Dominic Chih-Cheng Voon; Suk-Chul Bae; Yoshiaki Ito
Journal:  Blood       Date:  2008-08-11       Impact factor: 22.113

10.  The corepressor mSin3A regulates phosphorylation-induced activation, intranuclear location, and stability of AML1.

Authors:  Yoichi Imai; Mineo Kurokawa; Yuko Yamaguchi; Koji Izutsu; Eriko Nitta; Kinuko Mitani; Masanobu Satake; Tetsuo Noda; Yoshiaki Ito; Hisamaru Hirai
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.